AU2001233965A1 - Novel cd23 inhibitors - Google Patents

Novel cd23 inhibitors

Info

Publication number
AU2001233965A1
AU2001233965A1 AU2001233965A AU3396501A AU2001233965A1 AU 2001233965 A1 AU2001233965 A1 AU 2001233965A1 AU 2001233965 A AU2001233965 A AU 2001233965A AU 3396501 A AU3396501 A AU 3396501A AU 2001233965 A1 AU2001233965 A1 AU 2001233965A1
Authority
AU
Australia
Prior art keywords
inhibitors
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233965A
Inventor
Gordon Bruton
Barry Sidney Orlek
Kishore Rana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0004414A external-priority patent/GB0004414D0/en
Priority claimed from GB0031271A external-priority patent/GB0031271D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2001233965A1 publication Critical patent/AU2001233965A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
AU2001233965A 2000-02-24 2001-02-23 Novel cd23 inhibitors Abandoned AU2001233965A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0004414A GB0004414D0 (en) 2000-02-24 2000-02-24 Novel compounds
GB0004414 2000-02-24
GB0031271A GB0031271D0 (en) 2000-12-21 2000-12-21 Novel compounds
GB0031271 2000-12-21
PCT/GB2001/000807 WO2001062715A1 (en) 2000-02-24 2001-02-23 Novel cd23 inhibitors

Publications (1)

Publication Number Publication Date
AU2001233965A1 true AU2001233965A1 (en) 2001-09-03

Family

ID=26243724

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233965A Abandoned AU2001233965A1 (en) 2000-02-24 2001-02-23 Novel cd23 inhibitors

Country Status (5)

Country Link
US (1) US20030134880A1 (en)
EP (1) EP1265855A1 (en)
JP (1) JP2003523994A (en)
AU (1) AU2001233965A1 (en)
WO (1) WO2001062715A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ541064A (en) 2003-03-07 2007-09-28 Kowa Co Benzofuran derivative
EP1648868B1 (en) * 2003-06-19 2006-11-15 Celltech R & D Limited Hydroxamate sulfonamides as cd23 shedding inhibitors
WO2004113312A1 (en) * 2003-06-19 2004-12-29 Celltech R & D Limited Hydroxamate sulfonamides as cd23 shedding inhibitors
WO2005073180A1 (en) * 2003-12-25 2005-08-11 Kureha Corporation Hydroxamic acid derivative and age generation inhibitor containing the derivative
CA3018486C (en) 2016-03-31 2024-02-20 Kentaro Ishihara Method for producing 5-(bromomethyl)-1-benzothiophene

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
GB9414157D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Medical use
AU715764B2 (en) * 1996-01-23 2000-02-10 Shionogi & Co., Ltd. Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
GB9706255D0 (en) * 1997-03-26 1997-05-14 Smithkline Beecham Plc Novel compounds
DE69910542T2 (en) * 1998-02-06 2004-06-09 Darwin Discovery Ltd., Slough HYDROXAMIC ACID AND CARBONIC ACID DERIVATIVES
GB9813451D0 (en) * 1998-06-22 1998-08-19 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
EP1265855A1 (en) 2002-12-18
WO2001062715A1 (en) 2001-08-30
US20030134880A1 (en) 2003-07-17
JP2003523994A (en) 2003-08-12

Similar Documents

Publication Publication Date Title
AU2001258771A1 (en) -secretase inhibitors
AU2001237041A1 (en) Kinase inhibitors
AU2002219555A1 (en) VLA-4 Inhibitors
AU2001273040A1 (en) Factor xa inhibitors
AU2002250394A1 (en) Rho-kinase inhibitors
AU2002245709A1 (en) Rho-kinase inhibitors
AU2001296961A1 (en) 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
AU2003249442A1 (en) Kinase inhibitors
AU2003222055A1 (en) Kinase inhibitors
AU2001293373A1 (en) 2-guanidino-4-arylchinazolines as NHE-3 inhibitors
AU2002220241A1 (en) Parb inhibitors
AU2002211663A1 (en) Nf-$g(k)b inhibitors
AU6381701A (en) Bisamidino compounds as nhe-3 inhibitors
AU5248800A (en) Fading inhibitors
AU2001294557A1 (en) Thrombin inhibitors
AU2001236052A1 (en) Urease inhibitors
AU2002222627A1 (en) Tak1 inhibitors
AU2002211662A1 (en) Nf-kappab inhibitors
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2002322802A1 (en) Thrombin inhibitors
AU2001255090A1 (en) Cdk inhibitors having 3-hydroxychromen-4-one structure
AU2001241917A1 (en) Myt1 kinase inhibitors
AU2002222628A1 (en) Keratinocyte proliferation inhibitors
AU2002351076A1 (en) Thrombin inhibitors
AU2001233965A1 (en) Novel cd23 inhibitors